Harmon Seth 4/A

What Happened
Seth Harmon, Chief Financial Officer of Viridian Therapeutics (VRDN), disposed of 2,031 shares on March 3, 2026 to satisfy tax withholding obligations related to a prior equity transaction. The shares were disposed at $30.19 each for a total value of approximately $61,316. This filing is an amendment correcting the previously reported number of shares and price sold to cover taxes.

Key Details

• Transaction date and price: 2026-03-03 — 2,031 shares at $30.19 per share (total ~$61,316).
• Transaction code: F (payment of exercise price or tax liability / shares withheld/sold to cover taxes).
• Filing: Amended Form 4 filed 2026-03-09 correcting the initial Form 4 filed March 4, 2026 (per footnote F1).
• Shares owned after transaction: Not specified in the provided excerpt; the amendment corrects the resulting total beneficial ownership reported in the initial Form 4.
• This was not an open-market purchase or sale for investment cash proceeds but a routine tax-withholding disposition following an equity event.

Context
Tax-withholding share disposals (code F) are common after option exercises or vesting events and do not necessarily signal an insider view on the company’s prospects. The amendment merely corrects previously reported counts/prices—no new trading pattern or 10b5-1 plan is indicated in the provided details.